Several weight-loss drug stocks are sliding today as pharmaceutical companies battle for dominance in the booming GLP-1 market — which is projected to hit $105 billion by 2030, according to Morgan Stanley (MS) analysts.
Read more...
Read More Details
Finally We wish PressBee provided you with enough information of ( Hims & Hers, Zealand, and Roche — why these weight loss drug stocks are down today )
Also on site :
- Automechanika Istanbul 2025, Dijital Pazar Yeri Truck1 ile Medya Ortaklığı Kurdu
- Bidders Line Up to Buy Macquarie’s $3.6-Billion Industrial Gas Firm
- As Robotaxi Rides Begin, We Still Don't Know the Mystery of Tesla’s Human Helpers